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sinki. Deep brain stimulationwas carried out with the adequate un-
derstanding and written consent of the patient involved and with
the ethical approval of the authors’ institutional review board.
Deep brain stimulation (DBS) of the subthalamic nucleus (STN)
is a safe and effective treatment for Parkinson’s disease (PD). How-
ever, small variations in stimulation current can cause excessive
neural activation of neighboring anatomical structures or the
non-motor portions of the STN which might induce unintended
side effects. Therefore, in a number of patients, this leads to the
dilemma of choosing suboptimal stimulation parameters to avoid
side effects at the cost of suboptimal suppression of motor symp-
toms. In conventional, single-source DBS systems (voltage- and
current-control systems), precision and stability of therapy delivery
may be limited since each contact cannot be controlled indepen-
dently. In contrast, simulation models of DBS indicate that current
steeringwithmultiple stimulation sourcesmight be able to transfer
current more precisely and more constant over time [1,2]. In prin-
ciple this approach might be a helpful tool for the clinician to con-
trol side effects thereby improving the overall outcome of DBS.
Here, we report of our experience with a novel DBS-system
capable of multiple source current steering and describe how
this novel programming capability added to a more customized
DBS-programming in a PD patient treated with bilateral STN-
DBS. This case report is in accordance with the Declaration of
Helsinki. Deep brain stimulation was carried out with the
adequate understanding and written consent of the patient
involved and with the ethical approval of the authors’ institu-
tional review board.
A 60 year old male diagnosed with PD for 13 years presented
at our clinic. He suffered from severe parkinsonism, resting and
postural tremor more dominant on the left side, and a history of
depressive symptoms. Dopaminergic drugs induced severe sleep
apnea and day-time sleepiness. The patient experienced off-
time freezing of gait episodes and severe dyskinesia, limiting
his daily activities and quality of life. The patient reportednse (http://creativecommons.having normal mobility for only 4–6 h per day. The UPDRS III
score was 45 points (off medication) and 10 points in the on-
medication state after administration of 200 mg of soluble L-
Dopa (Madopar LT, Roche) which is a L-Dopa response of almost
80%. Medication reached a daily L-dopa dosage of 800 mg, in
addition to 2.1 mg of pramipexole. Medications improved
UPDRS III scores but also resulted in severe dyskinesia. The med-
ical treatment was not found to be effective in controlling the
patient’s symptoms resulting in social life exclusion due to se-
vere impairment.
In November 2010 bilateral DBS of the STN was performed with
a DBS system capable of multiple source current steering (Boston
Scientiﬁc DBS, 8-contact lead, Vercise Implantable Pulse gener-
ator, Boston Scientiﬁc Corporation, Natick, MA, USA). Intraopera-
tively, rigidity, tremor and hypokinesia responded well to test
stimulation, microelectrode recordings detected speciﬁc STN activ-
ity at the target area and electrode localizationwas conﬁrmed with
intra- and postoperative stereotactic orthogonal X-ray and postop-
erative CT. The days after implantation we saw a marked stun-
effect. A monopolar review one week after implantation identiﬁed
contact #2 on both electrodes to be best for suppression of motor
signs. Whereas the left electrode was programmed with a simple
monopolar setting, the right electrode controlling the left - more
affected – hemibody needed more ﬁne tuning. In the following,
the programming steps over the course of several months are out-
lined in detail: Monopolar stimulation of the right STN – through
contact #2 with a pulse width of 60 ms, frequency of 130 Hz and
amplitude of 2 mA, led to motor improvement (Fig. 1A). However,
further increasing the amplitude on contact #2 induced dyskinesia,
and was insufﬁcient to completely control the patient’s tremor. We
therefore adjusted the stimulation ﬁeld into a ‘teardrop-shape’ by
shifting the stimulation toward a more proximal contact (contact
#3), and slowly increasing amplitude. This resulted in improve-
ment in motor symptoms, without driving dyskinesia (Fig. 1B).
The patient also continued to experience some apathy, and prob-
lems with mood and drive possibly also by reduction of dopami-
nergic medication postoperatively. Apathy could be reduced
through monopolar stimulation of contact #1 with very low ampli-
tude possibly through affection of the limbic portion of the STN [3]
(Fig. 1C). In another follow-up visit, the patient suffered from slight
aggravation of resting tremor and also dyskinesia which prompted
us to additionally activate contact #4 which led to tremor improve-
ment possibly via affection of the zona incerta [4] and dyskinesia
possibly through stimulation of pallidofugal ﬁber tracts [5]. In order
Fig. 1. Right-sided electrode location is shown in anatomical relation to the thalamus (yellow), STN (green) and red nucleus (red). A: 100% stimulation on contact #2 with 2.0 mA,
60 ms, 130 Hz which resulted in motor improvement but also induced dyskinesia. B: By shifting the current more dorsally (84% on contact #2, 16% on contact #3, at 2.0 mA) motor
symptoms improved further without driving dyskinesia. C: Additional activation of contact 1 (10% on contact #1, 75% on contact #2, 15% on contact #3, at 2.0 mA) reduced apathy
possibly by affection of the limbic portion of the STN. After ﬁxation of the electrodes at the burr hole we saw mild lead deviation of the electrode which resulted in a ﬁnal lead
location 2 mm too rostrally. Still the patient did beneﬁt from an excellent clinical effect as described in the manuscript so that the electrode location did not have to be corrected.
The rostral location might explain the proximity of contact #1 to the limbic portion of the STN. D: Activation of contact 4 located in the zona incerta resulted in further improvement
of tremor and dyskinesia. The Boston Scientiﬁc GUIDE DBS System was used to generate the ﬁgure. This system locates the lead in the anatomy through the following steps: A pre-
operative MRI is fused to a post-operative CT. The Morel atlas [7] is registered to the pre-operative MRI. An automated algorithm locates the lead in a post-operative CT.
Table 1
Activated contacts (left), distribution of current (middle) and possible pathophysio-
logical mechanism of action (right) in our patient with Parkinson’s disease and mul-
tiple source deep brain stimulation of the subthalamic nucleus. Note, that the
different distribution of current is targeting different anatomical structures and, clin-
ically, different clinical symptoms.
Number of
contact
(from
ventral
to dorsal)
Percentage of current
applied to the tissue
Possible mechanism of action
1 10% current stimulation
(0.6 mA)
We assume that the improvement
of apathy was due to the stimulation
of the limbic portion of the STN [3]
2 50% current stimulation
(3 mA)
Monopolar review identiﬁed this
contact as the best single therapeutic
contact, and a major part of the
current is delivered through this
contact for good overall motor outcome
3 10% current stimulation
(0.6 mA)
We stimulated through this contact
to reshape the ﬁeld and maintain
the clinical effect of contact #2
without driving dyskinesia side effects.
4 30% current stimulation
(1.7 mA).
We assume that the further
improvement in tremor and dyskinesia
was due to the stimulation of the
zona incerta (tremor) [4] and
pallidofugal ﬁber-tracts (dyskinesia)
[5] crossing the white matter located
dorsal to the STN.
Letter to the Editor / Parkinsonism and Related Disorders 20 (2014) 471–473472to combine those optimal settings - we decided to deliver simulta-
neous and independent stimulation through the 4 contacts
(Fig. 1D). Overall current amplitude on the right STN lead was
then at 5.9 mA (pulse width of 60 ms and frequency of 130 Hz
remained unchanged). We were able to simply reshape the electri-
cal ﬁeld along the 4 contacts and fractionalize the current as shown
in Table 1. Of course our topographic explanations of the observed
effects are merely hypothetical since we neither have proof that the
zona incerta or the limbic portion of the STN are in fact affected by
stimulation nor that affection of these areas would reliably lead to
the observed changes. L-dopa dose reduction was remarkable –
decreased by 70%, 3 months after the surgery and by 100% today.
The UPDRS motor score improved from 45 points without therapy
to 15 points with DBS. Over two years later in January 2013, the pa-
tient was still reporting excellent results from current steering,
with clear speech, good gait, excellent postural reﬂex, no rest
tremor, and only tiny action tremor.
This is the ﬁrst report of the effects of multiple source current
steering in human. As we could show in previous studies, path-
ological activity in PD patients is clustered along the STN and ZI,
thus, customized stimulation on different contacts is reasonable
[6]. In former times stimulating multiple contacts might have
been limited by the high amounts of current used consequently
shortening battery life. With the rechargeable system used in
this case study, battery depletion and reduced battery life was
Letter to the Editor / Parkinsonism and Related Disorders 20 (2014) 471–473 473not a clinically relevant restriction. Current steering based on a
precise monopolar review led to a good reduction of all motor
symptoms while minimizing side effects. The current steering
stimulation strategy was successful in improving motor scores
and distinct therapeutic beneﬁts on dyskinesia, tremor, and
apathy without causing unwanted side effects. Of course the ma-
jority of PD patients can be sufﬁciently treated with a simple
monopolar voltage or current stimulation. A robust comparison
of the clinical effects achievable by single source systems
(voltage or current) to the clinical effects achievable by current
steering with multiple independent current sources has not
been performed. However, when more contacts need to be acti-
vated (as in the case described) programming opportunities of
conventional systems are limited to timing-based strategies
(e.g., sequential interleaving of two ﬁelds) or a limited current-
control mode. In sum, the effective degrees of freedom for DBS
programming are higher with the Vercise-system. If this will
result in better performance of DBS in PD has to be shown in
future studies.Conﬂict of interest
All authors report no conﬂict of interest.Financial disclosure
Michael Barbe received honoraria for speaking engagements
from GE Medical and Medtronic Inc. and travel grants from Med-
tronic Inc.
Mohammad Maarouf received honoraria for speaking engage-
ments from Medtronic Inc.
Francois Alesch has no ﬁnancial disclosure to report of.
Lars Timmermann received payments as a consultant for
Medtronic Inc, Boston Scientiﬁc, Bayer Healthcare, UCB Schwarz
Pharma. L.T. received honoraria as a speaker on symposia spon-
sored by TEVA Pharma, Lundbeck Pharma, Bracco, Gianni PR,
Medas Pharma, UCB Schwarz Pharma, Desitin Pharma, Boeh-
ringer Ingelheim, GlaxoSmithKline, Eumecom, Orion Pharma,
Medtronic, Boston Scientiﬁc, Cephalon, Abott, GE Medical, Archi-
medes, Bayer. The institution of L.T., not L.T. personally received
funding by the German Research Foundation, the German Minis-
try of Education and Research, Manfred und Ursula Müller Stif-
tung, Klüh Stiftung, Hoffnungsbaum e. V., NBIA DISORDERS
SOCIETY USA, Köln Fortune, Medtronic, Deutsche Parkinson Ver-einigung. Archimedes Pharma, Abott, Bayer, UCB, zur Rose
Pharma, TEVA.References
[1] Butson CR, McIntyre CC. Current steering to control the volume of tissue acti-
vated during deep brain stimulation. Brain Stimulation 2008;1:7–15.
[2] Chaturvedi A, Foutz TJ, McIntyre CC. Current steering to activate targeted neural
pathways during deep brain stimulation of the subthalamic region. Brain Stim-
ulation 2012;5:369–77.
[3] Mallet L, Schupbach M, N’Diaye K, Remy P, Bardinet E, Czernecki V, et al. Stim-
ulation of subterritories of the subthalamic nucleus reveals its role in the inte-
gration of the emotional and motor aspects of behavior. Proceedings of the
National Academy of Sciences of the United States of America 2007;104:
10661–6.
[4] Alterman RL, Shils JL, Gudesblatt M, Tagliati M. Immediate and sustained relief
of levodopa-induced dyskinesias after dorsal relocation of a deep brain stimu-
lation lead. Case report. Neurosurgical Focus 2004;17. E6.
[5] Herzog J, Pinsker M, Wasner M, Steigerwald F, Wailke S, Deuschl G, et al. Stim-
ulation of subthalamic ﬁbre tracts reduces dyskinesias in STN-DBS. Movement
Disorders: Ofﬁcial Journal of the Movement Disorder Society 2007;22:679–84.
[6] Reck C, Florin E, Wojtecki L, Krause H, Groiss S, Voges J, et al. Characterisation of
tremor-associated local ﬁeld potentials in the subthalamic nucleus in Parkin-
son’s disease. The European Journal of Neuroscience 2009;29:599–612.
[7] Krauth A, Blanc R, Poveda A, Jeanmonod D, Morel A, Szekely G. A mean three-
dimensional atlas of the human thalamus: generation from multiple histologi-
cal data. NeuroImage 2010;49:2053–62.Michael T. Barbe
Department of Neurology, University Hospital Cologne,
Cologne, Germany
Cognitive Neuroscience (INM3), Institute of Neuroscience and
Medicine, Research Centre Jülich, Germany
Mohammad Maarouf
Department of Stereotaxy and Functional Neurosurgery,
University Hospital Cologne, Cologne, Germany
Francois Alesch
Neurosurgical Department, Medical University of Vienna,
Vienna, Austria
Lars Timmermann*
Department of Neurology, University Hospital Cologne,
Kerpener Str. 62, D-50937 Cologne, Germany
* Corresponding author. Tel.: þ49 221 4787494;
fax: þ49 221 87512.
E-mail address: lars.timmermann@uk-koeln.de (L. Timmermann)
22 April 2013
